2017 MASCC/ISOO Annual Meeting Study Group Workshops

Workshops:  2019  |  2018  |  2017  |  2016  |   2015  |  2014  |  2013  |  2012  |  2011 

How Adherence to Guidelines Increases the Cost-Effectiveness of Supportive Care Interventions
The need to increase the cost-effectiveness of medical treatments is recognized around the globe. One way to increase cost-effectiveness of medical treatments is by following evidence-based guidelines that consider cost containment. This workshop explored evidence for the need to adhere to such guidelines, both to improve outcomes and to ensure that available resources are used in the most appropriate manner. It included a review of current guidelines and possible negative consequences of non-adherence, stressing the importance of a multidisciplinary approach to cancer treatment and supportive care. This workshop was offered jointly by the following MASCC Study Groups: Antiemetics; Neutropenia, Infection, and Myelosuppression; Oral Care;  Psychosocial.
Workshop Chair: Bernardo Rapoport

Update on Venous Thromboembolism: Approach and Challenges
This workshop, held jointly by the Hemostasis and Education Study Groups, brought together a multinational group of experts to review current evidence and needed knowledge regarding cancer-associated venous thromboembolism (VTE). It included discussions of the clinical challenges and promoted the education of patients, providers, and family members. Workshop presentations are listed below and slide sets are available for review. Workshop Chairs: Carme Font, Carmen Escalante, Thomas Butler, Paz Fernández-Ortega

 Workshop Presentations & Slides

Primary Thromboprophylaxis for Cancer Outpatients on Chemotherapy: Case Study 
Carme Font, MD, Medical Oncology Department, Hospital Clinic Barcelona, Barcelona, Spain

Primary Thromboprophylaxis in Ambulatory Cancer Patients: Current Guidelines and Updated Evidence 
Taylor Butler, PharmD, BCOP, Department of Veteran Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee, USA

Patient-Centered Treatment of Cancer-Associated VTE. Does One Size Fit All?  
Simon Noble, MD, FRCP, Cardiff University, Wales, UK

Shared Decision-Making in Anticoagulation: Patient, Provider, Family / Friends 
Annie Young, University of Warwick and University Hospitals Coventry and Warwickshire, Great Britain, UK

Update on Direct Oral Anticoagulants: A Perspective Beyond the Cancer VTE Guidelines 
Chrishiam M. Rojas-Hernandez, MD, MD Anderson Cancer Center,  Houston, Texas. USA

Challenging Case Study: VTE Treatment — “How Long Is Long Enough?” 
Thomas W. Butler, MD, FACP, University of South Alabama, Mitchell Cancer Institute, Mobile, Alabama, USA

Best Practices: Approaches to Educating and Engaging Patients on VTE Prevention 
by Judy Phillips, DNP, FNP-BC, AOCN, Cancer Care of Western North Carolina, Lenoir-Rhyne University, North Carolina, USA

Integration of Oncology and Palliative Care:  Why? What? Who? When? How?
This workshop explored the integration of oncology and palliative care through the combination of complex case studies, panel discussion, and active audience participation. Presenters reviewed conceptual models related to such integration and ways in which integration is implemented at academic cancer centers, as well as in community clinics. Topics included the timing of referrals to palliative care specialists and ways to discuss referrals with patients and their families. Differences between referrals for pediatric and adult patients were also considered. This workshop was offered jointly by the following MASCC Study Groups: Education, Palliative Care; Pediatrics.
Workshop Chair: David Hui

Communication Challenges in Geriatric Oncology: Perspectives of Patients, Family Caregivers, and Healthcare Professionals
The purpose of this workshop was to foster interdisciplinary learning and skills practice in the area of communication and quality of life with a focus on older patients and family caregivers. It included interactive and experiential learning exercises, such as role playing, video triggers to facilitate group discussion, and demonstration of communication skills by expert facilitators. Case study discussions focused on communication and strategies for improving the patient experience throughout the cancer trajectory. This workshop was offered jointly by the following MASCC Study Groups: Geriatrics; Psychosocial.
Workshop Chairs: Christopher Steer, Lidia Schiapira, Penny Schofield, Fran Boyle, Holly Holmes, Belinda Kiely

Circadian Rhythms and Chronobiology in Cancer: Relationship to Cancer-related Fatigue and Other Toxicities
One of the most difficult challenges faced by both clinicians and researchers is that of understanding the mechanisms involved in the etiology of toxicities related to cancer and its treatment. A primary example of such a toxicity is fatigue. However, the task is particularly challenging when severe toxicities coexist and treatment options are not well defined. The goal of this workshop was to educate clinicians and researchers about potential mechanisms of toxicity, especially those that can give rise to multiple adverse events. Circadian phenomena have strong and direct implications for fatigue, sleep problems, delirium, pain, and other toxicities. A better understanding of the relationships involved can help clinicians choose treatments and help researchers develop new and maximally effective therapies. This workshop was offered jointly by the following MASCC Study Groups: Fatigue; Palliative Care; Rehabilitation, Survivorship, and Quality of Life.
Workshop Chairs: Oxana Palesh and Diwakar Balachandran